Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-518P (RNA, U6 small nuclear 518, pseudogene)** is a member of the U6 small nuclear RNA pseudogene family. U6 snRNA (not the pseudogene) plays a critical role as part of the spliceosome, essential for pre-mRNA splicing in the nucleus of eukaryotic cells[3][5]. However, RNU6-518P itself is a **pseudogene**, meaning it is a genomic sequence similar to the active U6 small nuclear RNA gene but typically non-functional and not transcribed into a functional RNA or protein[1][2][3]. Most pseudogenes like RNU6-518P are presumed to have no biological function and are not considered therapeutic targets[2][1]. While some pseudogenes can be involved in gene regulation or act as sources for non-coding regulatory RNAs, there is no evidence that RNU6-518P plays an active biological or disease-related role, and no drugs specifically target this gene or its product[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 518, pseudogene (RNU6-518P).